Neonatal Med.  2015 May;22(2):71-77. 10.5385/nm.2015.22.2.71.

Prognosis and Side Effects of Inhaled Nitric Oxide Treatment in Persistent Pulmonary Hypertension of the Newborn

Affiliations
  • 1Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. yoon.ahn.neo@gmail.com

Abstract

Inhaled nitric oxide (iNO) is a potent and selective pulmonary vasodilator agent that improves arterial oxygenation and subsequent clinical outcomes for newborn infants with persistent pulmonary hypertension of the newborn (PPHN). Along with beneficial pharmacological properties, iNO also shows toxicological effects. Although the side effects of iNO have not been fully understood, these need to be thoroughly considered and monitored for the safe and effective clinical use of iNO. This article presents a review of the side effects of iNO and short-term and long-term clinical prognosis in newborn infants > or =34 weeks' gestation with PPHN.

Keyword

Nitric oxide; Infant newborn; Persistent fetal circulation syndrome

MeSH Terms

Female
Humans
Hypertension, Pulmonary*
Infant, Newborn*
Nitric Oxide*
Oxygen
Persistent Fetal Circulation Syndrome
Pregnancy
Prognosis*
Nitric Oxide
Oxygen
Full Text Links
  • NM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2022 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr